4-Oxo-1-propyl-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxylic acid, 97%, 100mg

1-(3-FLUOROPHENYL)CYCLOPENT-3-ENOL, 95.0%, 1g

5-bromo-1-methyl-3-(trifluoromethyl)-1H-pyrazole, 95.0%, 25g

3-bromo-6-fluoroimidazo[1,2-a]pyridine, 95.0%, 1g

3,5-Bis(trifluoromethyl)benzeneboronic acid, 98.0%, 100mg

1-(3-Bromo-4-fluorophenyl)ethanol, 95.0%, 1g

5-Bromo-2-(methoxymethoxy)benzaldehyde, 98%, 100mg

2,4-Dichloro-6-fluorophenylboronic acid, 98%, 5g

(2E)-N,N-Dimethyl-3-(pyridin-4-yl)prop-2-enamide, 95.0%, 25g

Ethyl 2-(methylthio)pyrimidine-5-carboxylate, 95.0%, 1g

2-{[3-(4-Chlorophenyl)-1-phenyl-1H-pyrazol-4-yl]methylidene}-5,5-dimethylcyclohexane-1,3-dione, 25mg

ROTI®Pol TaqS, 100 µl, 1 x 100 µl

Bromuro de potasio, mínimo 99 %, pa, ACS, 100 g, envase de plástico.